A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated

With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.

“While others back into the future, we lead the way forward—with curiosity, with science, with knowledge, but also compassion as our guiding star,” said Aida Hadžialić, Finance Regional Councilor and Chair of the Regional Executive Board in Region Stockholm, at the inauguration.

More than 600 participants from industry, academia, municipalities, and society gathered in Flemingsberg to celebrate the shared goal: accelerating the development and accessibility of tomorrow’s treatments.

“Advanced therapies represent a paradigm shift. They offer possibilities that were previously unimaginable,” stated Annika Östman Wernerson, President of Karolinska Institutet.

Throughout the day, ongoing research and breakthroughs were presented in cell and gene therapy, treatment of neonatal lung disease, Parkinson’s disease, and immunotherapies. The program highlighted the pioneering progress already being made within ATMP in Flemingsberg, where the center symbolizes a major investment in accelerating the work of future medicine even further. Knut Steffensen, Director of the Karolinska ATMP Center, summarized the vision:

We will cure and alleviate tomorrow, what no one can cure and alleviate today.”

With the Karolinska ATMP Center now officially inaugurated, the work on future medicine takes a major step forward – where collaboration, knowledge, and compassion go hand in hand to give patients hope for a brighter future. At Flemingsberg Science Foundation, we are proud to have supported this important day for future medicine and treatments, and to celebrate all those working to drive progress forward.

OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg

Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on the Flemingsberg Campus. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.

Drivhuset Stockholm – Where Future Entrepreneurs Take Their First Steps

Imagine a place where young ideas are free to grow, where passion meets ambition, and where the entrepreneurs of tomorrow take their first steps toward greatness. That’s exactly what Drivhuset Stockholm offers – a springboard for the next generation of entrepreneurs. Located on Campus Flemingsberg, we support students every day as they bring their ideas to life and build the skills needed to create real change. Our mission? To provide them with a safe, inspiring environment where they can test and develop their business ideas for real.

Go to Top